Introduction
The risk of developing chronic diseases is increased in older adults (1) (2) (3) (4) (5) , and an elevated level of circulating inflammatory markers are often observed (3, 6) . Growing evidence indicates that inflammatory markers, such as high-sensitive C-reactive protein (hs-CRP), interleukin 6 (IL6), and tumor necrosis factor alpha (TNFα), are associated with loss of muscle mass and muscle strength (7) (8) (9) (10) (11) (12) (13) (14) (15) , possibly contributing to the development of sarcopenia (13, 16, 17) .
Dietary strategies to prevent the onset of chronic, low-grade inflammation are therefore suggested to improve several health outcomes and to prolong longevity among elderly (3, 6, 18, 19) . Foods, including fruits and vegetables, fish, whole grains and some vitamins, are shown to exert anti-inflammatory effects (2) . The effects of dairy products on inflammatory markers are less clear (20) . Some epidemiological evidence indicates that low-fat dairy products are inversely associated with the level of inflammatory markers among healthy adults (21-23), but the data are inconclusive (24). In randomized controlled trials a reduction in the circulating levels of TNFα, IL6 and chemokine (C-C motif) ligand 2 (CCL2) have been shown after consuming dairy products in obese subjects (25, 26) , but the data are not conclusive (27, 28) . A reduction of the same inflammatory markers have been observed in subjects with the metabolic syndrome (29), but not in healthy adults (30, 31), nor in adult subjects with an elevated level of hs-CRP (32) after consuming dairy products.
High protein diets have increased in popularity, and these are widely used in combination with weight reduction (33) and in sports nutrition (34) to preserve muscle mass and promote muscle strength. Few have examined the possible effects of high protein diets on risk factors for chronic diseases (24, [35] [36] [37] , among them level of inflammatory markers (38, 39) . No negative effects on inflammatory markers are observed (38, 39) , but long-term clinical studies are scarce (38) (39) (40) .
In a double-blind randomized controlled intervention study, we investigated whether an increased daily intake of a low-fat, protein-enriched milk could alter markers of inflammation in peripheral mononuclear blood cells (PBMCs) and in serum among community dwelling elderly men and women above the age of 70 years with reduced muscle strength and functional performance.
Materials and methods

Study population and study design
The present study is part of a research project were men and women (≥ 70 years) living at home were recruited to a 12 week double-blind, randomized controlled intervention trial, conducted from August 2014 to September 2015 at Oslo and Akershus University College of Applied Sciences, Norway. The primary aim of this study was to investigate the effect of increased intake of protein-enriched milk on muscle mass and physical strength. A detailed description of participant recruitment, enrollment, selection criteria, and compliance are given elsewhere (41) . In brief, 2820 subjects were invited to participate in the study. 438 subjects met to screening of which 388 were excluded. Thus, 50 older subjects, with either reduced hand grip strength (< 20 kg in women and < 30 kg in men), gait speed < 1 m/s, timed step stair test ≥ 8.4 s or timed five times sit to stand test > 12.5 s, and otherwise weight stable and apparently healthy, were randomized. Among the exclusion criteria were a Mini-Mental State Examination score < 24, a Mini Nutritional Assessment score < 17 and high intakes of dairy products (≥ 4 dl/day of milk, cultured milk and/or yoghurt). In total, 36 subjects completed the study. The intervention group received a protein-enriched milk (n= 17, 2 x 0.4 L/d; 2 x 20 g protein/d), whereas the control group received an isocaloric carbohydrate drink (n=19, 2 x 0.4 L/d), for 12 weeks. The subjects consumed the test drinks together with breakfast and the evening meal, and they were encouraged to maintain their habitual diet and physical activity level throughout the study period.
All subjects provided written informed consent, and we conducted the study according to the Declaration of Helsinki. We received approval for all procedures involving human subjects by the Regional Committees for Medical and Health Research Ethics, Health Region South East, Norway. The study was registered at Clinicaltrials.gov (ID no. NCT02218333).
Study products
TINE SA (Oslo, Norway) produced and provided the protein-enriched milk and the isocaloric control drink. The protein-enriched milk contained on average 5.0% protein, 4.6% carbohydrates, < 0.1% fat and provided approximately 167 kJ (39 kcal)/100 g. The control drink was prepared from carbohydrates (sugar, xantan gum and Maltosweet TM ). To give the control drink a milky appearance the producer added titandioksid (E171). Both drinks contained approximately 178 mg/100 g of calcium. RNA quantity was measured using NanoDrop-1000 (NanoDrop Technologies, Inc., Delaware, USA), while RNA quality was checked with Aglient 2100 Bioanalyzer (Agilent Technologies, Inc., California, USA). All PBMC samples included in further analysis had a RIN-value above 9. One participant was excluded from further analysis due to low mRNA content in one of the PBMC samples.
Blood sampling and sample preparation
Synthesis of cDNA
Complementary DNA (500 ng) was made using a RNA to cDNA kit from Applied Biosystems (Applied Biosystems, UK) in accordance with the manufacturer's protocol.
Samples were stored at -20 °C for further analysis.
RNA analysis/Real-time qPCR
We analyzed mRNA levels of 48 genes using TaqMan Low-Density array (TLDA) cards from 
CRP and cytokine measurements
The serum levels of interleukin 10 (IL10), interferon gamma (IFNG) and TNFA were measured using a Magnetic Luminex Performance Assay (R&D Systems Inc., Minneapolis, USA) in accordance with the protocol provided. IL6 and sTNFRSF1A were analyzed using Quantikine ELISA (R&D Systems Inc., Minneapolis, USA) in accordance with the protocols provided. The levels of IL10 and IFNG were below the detection limit in the multiplex analysis. The inter-individual variation (CV) for IL6, TNFα and sTNFRSF1A were 6.5, 10.2 and 6.7%, respectively. All samples were measured in duplicates.
Statistics
Subjects were stratified by gender and smoking prior to a 1:1 block-randomization. Power calculations were made on the primary outcome of the study (muscle mass), as described elsewhere (41) . In all analysis, subjects with levels of hs-CRP above >10 mg/L at baseline (n=3) or at end of study (n=1) were excluded as such levels may indicate an ongoing inflammation. In total, samples from 14 participants in the protein group and 17 participants in the control group were analyzed.
We used non-parametric tests for statistical analysis of data not normally distributed. MannWhitney-test was used to determine possible differences between the study groups, while
Wilcoxon signed-rank test was used when investigating possible differences in variables between end of study and baseline within one study group. For normally distributed data, differences between study-groups at baseline were performed by the independent samples ttest. The Spearman correlation test was used to reveal possible correlations between the change in muscle mass and physical strength (chest press) with TNFA and sTNFRSF1A. Due to an explorative study design, correction for multiple testing was not performed. We considered a p-value of < 0.05 statistically significant. SPSS statistical software, version 22
from Microsoft (SPSS, Inc., USA), was used for statistical calculations. Table 1 shows baseline characteristics of the participants. There were no significant differences in gender, age, muscle mass, fat mass or BMI at baseline between the two study groups. As previously reported by Ottestad and colleagues (41), increased protein intake daily for 12 weeks did not significantly improve muscle mass, muscle strength or functional performance in healthy older and weight stable adults.
Results
Effects of protein-enriched milk on mRNA expression in PBMCs
In the present study, we analyzed mRNA levels of inflammatory markers in PBMCs in order to test if an increased intake of a low-fat, protein-enriched milk daily would alter these markers in adults > 70 years, when compared to an isocaloric intake of carbohydrates. We found that the change in mRNA levels of nuclear receptor subfamily, group H, member 3 (NR1H3), the gene that encodes for liver X receptor alpha (LXRα), and IFNG were significantly different between the two study groups after 12 weeks, whereas we observed no within-group changes for these genes in either of the two study groups (figure 1, panels A and Finally, we investigated possible changes in the distribution of cell types within the PBMC samples at baseline and end of study to be able to control for possible changes in the distribution of cell types. However, no differences were found in the distribution of cell types after the intervention period (supplementary table 4 ).
Effects of protein-enriched milk on serum levels of inflammatory markers
Based on the results from the mRNA analysis, we analyzed the effects of protein-enriched milk consumption on serum levels of sTNFRSF1A, TNFA and IL6. In contrast to the mRNA data, we found that the serum level of sTNFRSF1A increased significantly in both study groups (p=0.022 in the protein group, p=0.009 in the control group), whereas the serum level of TNFα increased in the control group (p=0.03), but with no statistically significant differences between the two study groups. The serum levels of IL6, hs-CRP and the ratio TNFα/sTNFRSF1A were not significantly different, neither within nor between the two study groups (table 2) .
We have previously reported that combining the two study groups, a significant improvement in muscle mass and chest press was observed from baseline to end of study (41) . In the present study, we observed a significant increase in serum levels of TNFA (p=0.001) and sTNFRSF1A (p=0.049) from baseline to end of study when combining the two study groups (n=31). However, we observed no relationship between the serum level of TNFA and muscle mass, r=-0.12 (p=0.54), or chest press, r=-0.13 (p=0.49) in the groups combined (n=31). Nor did we observed any relationship between changes in the serum level of sTNFRSF1A and muscle mass, r= 0.16 (p=0.40) (n=) or chest press, r=0.15 (p=0.43) in the groups combined (n=31).
Discussion
In the present study, we explored the impact of adding a daily intake of low-fat, high-protein milk to the regular diet of community-dwelling subjects > 70 years of age with reduced muscle strength and/or physical function, for 12 weeks, on inflammatory markers. Our data indicate that the intake of this milk had minor effects on mRNA expression and circulating inflammatory markers, compared to an isocaloric control drink containing carbohydrates only.
In the majority of studies where possible effects of consuming dairy products (25, 27, 28, 43), or high-protein diets (38, 39, 44-46) on circulating inflammatory markers were investigated, no significant effects on circulating markers, such as hs-CRP, IL6 or TNF were observed, supporting the results of the present study. We did observe a significant increase in the serum level of TNFα, but only in the control group receiving carbohydrates, indicating an increased TNFα activity in the control group. The serum level of sTNFRSF1A increased significantly in both groups after the intervention with no statistically significant changes between the two groups. The increased level of sTNFRSF1A in the protein group is in accordance with Van
Meijl and colleagues, who also found an increased level of sTNFRSF1A after providing overweight subjects (n = 35, mean age 49.5 yrs) with low-fat dairy products (500 ml milk and 150 g yoghurt, equals ~ 24 g protein, 1.5 MJ/day) daily for eight weeks. In contrast, they did not observe this effect in the control group who received 600 ml fruit juice and three fruit biscuits daily (1.7 MJ/day) (25). Van Meijl and colleagues suggested that these effects may be related to the content of calcium, as calcium has been shown to enhance the TNFα-signaling in human embryonic kidney cells (47) . In the present study, the calcium content was similar in the two drinks, suggesting that this effect may be independent of calcium.
Elevated circulating levels of hs-CRP, TNFα, IL6 and sTNFRSF1A have been associated with a decline in muscle mass (8) (9) (10) 12) and increased mortality in older adults (48, 49), but few randomized controlled trials have been performed investigating possible effects of consuming protein with the level of inflammatory markers in combination with muscle mass and muscle strength (13, 50) . Lower rates of muscle protein synthesis have also been associated with an upregulation of the NF-B pathway, a key regulator of inflammation (13) . Both TNFA and IL6 may activate the NF-B pathway (2, 51). Bartali and colleagues found an association between a low protein intake, high levels of TNF, IL6 and CRP and muscle strength in older subjects (13) . We have previously reported that the additional intake of 40 g protein or an isocaloric carbohydrate drink daily increased chest press after 12 weeks of intervention, in the groups combined (41) . We therefore investigated possible correlations between changes in muscle mass and chest press with changes in circulating levels of TNFA and sTNFRSF1A.
However, we observed no correlations between these parameters. In contrast to the subjects included in the study of Bartali and colleagues (13) , subjects included in the present study already had a protein intake within the recommended levels (52) at baseline (1.0 ± 0.3 g) (41).
This may be one explanation for observing no associations between changes in muscle mass, chest press and circulating levels of TNFα or sTNFRSF1A when additional protein was provided throughout the day.
After the intervention period, we observed a statistically significant difference in mRNA expression levels between the two study groups for two out of the 44 genes analyzed; NR1H3 In the protein group, we found no statistically significant changes in mRNA levels of any of the genes analyzed. These results are in accordance with data presented by Labonté and colleagues, who found no differences in mRNA expression levels of CCL2, IL18, IL6, IL1 or TNFA in whole blood after consuming three servings of dairy products daily, compared to an isocaloric amount of fruit-and vegetable juices, cashews and cookies (32). Fifty-three subjects with low-grade systemic inflammation were included in this randomized controlled trial (32). Van Loan and colleagues (27) also performed a randomized controlled trial, investigating possible effects of a high vs a low intake of dairy products daily (4 vs 0.5 serving/day). Seventy-one obese subjects were included in that study where they observed no changes in mRNA levels in adipose tissue of TNF, IL6, CCL2, IL1, IL10 or IL15 after the intervention period, supporting our mRNA data. Low-fat milk, yoghurt and full-fat cheese were provided in these studies (27, 32).
In the control group, we observed a 0.6 fold downregulation of TNFRSF1A mRNA expression (figure 2, panel A) and a 1.3 fold upregulation of DDP4 mRNA expression (figure 2, panel B), with no significant differences between the two groups. The upregulation of DDP4 may be related to the increased intake of carbohydrate in the control group. Simple carbohydrates may increase the activation of the NF-B pathway (2, 51), and both
TNFRSF1A and DDP4 are able to induce the transcription of inflammatory genes through this pathway (49). However, we observed no changes in target genes of the NF-B pathway (58), such as IL6, TNF, IL8, CCL2 and chemokine (C-C motif) ligand 3 (CCL3), in the control
group. The down-regulation of TNFRSF1A gene expression was in contrast to the increased serum level of sTNFRSF1A. Many other tissues (e.g. endothelial cell, adipose tissue and tissue macrophages) than PBMCs, may also contribute to the circulating levels of inflammatory markers, making the comparison between serum and PBMC levels difficult.
There are several methodological differences among the studies where intakes of dairy products/high-protein diets and potential implications on health are investigated, possibly explaining some of the conflicting results. The above-mentioned studies were performed in different groups (subjects with low-grade inflammation, the metabolic syndrome or obese subjects), different products were provided in the control groups, different levels and sources of protein were given and the metabolic status of the subjects included differed (39, (59) (60) (61) . In addition, dairy products are a heterogeneous group of foods that may exert different health effects. Most dairy products contain high levels of calcium, which is a component suggested to be able to suppress inflammation by inhibiting the production of inflammatory substances from adipose tissue through the inhibition of calcitriol (27, 29, 62) . In the present study, we supplied an equal amount of calcium to both groups, in an attempt to nullifying such an effect.
This may be a possible explanation for the lack of differences observed between the two study groups.
The major limitations of the present study were the few subjects included in the final analysis (n=31), that only a selection of markers known to be involved in chronic-low grade inflammation were analyzed, and that we measured the selected markers at mRNA level only.
Moreover, the present study did not include measurement of postprandial gene expression levels, which could have provided important insight into the acute response to the consumption of dairy protein compared to carbohydrates. Major strengths were the doubleblind randomized controlled design, the strictly controlled methodology, the isocaloric composition of the test products and the very high compliance to the experimental procedure of the subjects completing the study.
Conclusion
In the present study, we investigated possible effects of consuming a low-fat, protein-enriched milk, compared to an isocaloric carbohydrate drink, in older adults with reduced physical strength and/or functional performance, on mRNA levels in PBMCs and serum levels of selected inflammatory markers. Altogether, the results from the present study indicate that consuming low fat, protein-enriched milk for 12 weeks had minor effects on these markers, compared to an isocaloric control drink. Data are presented as mean  SD. No significant differences were observed between the two groups at baseline. 
